Target Practice in Inflammatory bowel disease (IBD) is organized by Gastrointestinal Health Foundation (GiHF) and will be held on Jun 04, 2020.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Cincinnati and the Gi Health Foundation (GiHF). The University of Cincinnati is accredited by the ACCME to provide continuing medical education for physicians.
The University of Cincinnati designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
After completing this program, participants should be better able to:
• Summarize current recommendations for selecting and assessing therapeutic targets in patients with Inflammatory Bowel Disease
• Describe the evidence regarding clinical, endoscopic and histological healing in Inflammatory Bowel Disease
• Differentiate current biologic and small molecule therapies used in Inflammatory Bowel Disease with respect to mechanisms of action, efficacy, and safety
This activity has been designed to meet the educational needs of gastroenterologists and other healthcare providers involved in the care of patients with inflammatory bowel disease (IBD).
Activity Payment Details
Reviews Given by Professionals
Live to Virtual Conference
Market your online event to Million plus Healthcare professionals.
Contact Ho 6
Contact Ho 2
Contact Ho 3
Contact Ho 4
Browse by Specialty (Online CME/CE Only) View All
- Clinical Pharmacology
- Emergency Medicine
- Endocrinology, Metabolism and Diabetes
- Healthcare Management
- Immunology and Microbiology
- Infectious Disease
- Medical Education
- Obstetrics and Gynecology
- Pain Management
- Pharmacy and Medicine
- Primary Care
- Pulmonary Medicine